Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Nike
62.9% sales growth and 28.27% return on equity
NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, and accessories worldwide.
Nike's sales growth this year is anticipated to be 15.6% and 11% for next year.
Year-on-year quarterly revenue growth grew by 8.9%, now sitting on 38.25B for the twelve trailing months.
Nike's sales growth for the next quarter is 62.9%. The company's growth estimates for the current quarter and the next is 41.5% and 200%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.27%.
Volatility
Nike's last day, last week, and last month's average volatility was 1.83%, 0.47%, and 0.21%, respectively.
Nike's last day, last week, and last month's high and low average amplitude percentage was 1.85%, 2.27%, and 1.91%, respectively.
Nike's Stock Yearly Top and Bottom Value
Nike's stock is valued at $146.35 at 07:22 EST, below its 52-week high of $147.95 and way above its 52-week low of $60.00.
Nike's Moving Average
Nike's value is higher than its 50-day moving average of $138.56 and way above its 200-day moving average of $119.49.Previous days news about Nike
According to Bloomberg Quint on Friday, 8 January, "For instance, Bank of America Corp., Sephora USA Inc. and Nike Inc. were among the companies that have either earmarked funds, formed task forces to address racial inequality orpledged support for Black-owned businesses."
2. Summit Financial Group, Inc.
26.1% sales growth and 11.36% return on equity
Summit Financial Group, Inc. operates as a financial holding company for Summit Community Bank, Inc. that provides community banking and other financial services to individuals and businesses primarily in the Eastern Panhandle, Southern and North Central regions of West Virginia and the Northern, and Shenandoah Valley and Southwestern regions of Virginia.
Summit Financial Group, Inc.'s sales growth this year is anticipated to be 23.6% and 8.5% for next year.
Year-on-year quarterly revenue growth grew by 22.2%, now sitting on 93.91M for the twelve trailing months.
Summit Financial Group, Inc.'s sales growth for the next quarter is 26.1%. The company's growth estimates for the current quarter and the next is a negative 29.2% and 68.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.36%.
Volatility
Summit Financial Group, Inc.'s last day, last week, and last month's average volatility was a negative 3.03%, a negative 0.19%, and a positive 0.26%, respectively.
Summit Financial Group, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 2.99%, 1.52%, and 2.21%, respectively.
Summit Financial Group, Inc.'s Stock Yearly Top and Bottom Value
Summit Financial Group, Inc.'s stock is valued at $22.08 at 07:22 EST, way under its 52-week high of $26.35 and way higher than its 52-week low of $13.48.
Summit Financial Group, Inc.'s Moving Average
Summit Financial Group, Inc.'s worth is above its 50-day moving average of $21.73 and way higher than its 200-day moving average of $17.46.3. Hologic, Inc.
75.7% sales growth and 46.05% return on equity
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, surgical products, and light-based aesthetic and medical treatment systems for women in the United States and internationally.
Hologic, Inc.'s sales growth this year is expected to be 35% and a negative 17.1% for next year.
Year-on-year quarterly revenue growth grew by 55.5%, now sitting on 3.78B for the twelve trailing months.
Hologic, Inc.'s sales growth is a negative 0% for the ongoing quarter and 75.7% for the next. The company's growth estimates for the present quarter and the next is 252.5% and 245.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 46.05%.
Volatility
Hologic, Inc.'s last day, last week, and last month's average volatility was a positive 1.51%, a negative 0.61%, and a positive 0.22%, respectively.
Hologic, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 2.50%, 2.73%, and 3.00%, respectively.
Hologic, Inc.'s Stock Yearly Top and Bottom Value
Hologic, Inc.'s stock is valued at $72.83 at 07:22 EST, under its 52-week high of $77.49 and way higher than its 52-week low of $26.49.
Hologic, Inc.'s Moving Average
Hologic, Inc.'s value is higher than its 50-day moving average of $72.09 and way above its 200-day moving average of $65.84.4. Baidu
25.3% sales growth and 11.1% return on equity
Baidu, Inc. provides Internet search services in China and internationally.
Baidu's sales growth this year is expected to be 8% and 15% for next year.
Year-on-year quarterly revenue growth grew by 0.5%, now sitting on N/A for the twelve trailing months.
Baidu's sales growth for the next quarter is 25.3%. The company's growth estimates for the current quarter and the next is a negative 29% and 47.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.1%.
Volatility
Baidu's last day, last week, and last month's average volatility was a positive 1.92%, a negative 1.12%, and a positive 1.82%, respectively.
Baidu's last day, last week, and last month's high and low average amplitude percentage was 4.45%, 4.86%, and 5.47%, respectively.
Baidu's Stock Yearly Top and Bottom Value
Baidu's stock is valued at $240.25 at 07:22 EST, higher than its 52-week high of $240.00.
Baidu's Moving Average
Baidu's value is way higher than its 50-day moving average of $171.04 and way above its 200-day moving average of $137.65.Previous days news about Baidu
According to Bloomberg Quint on Monday, 4 January, "Oft-cited candidates for secondary listings include Pinduoduo Inc., a fast-growing e-commerce company that listed in the U.S. in 2018, and Baidu Inc., the search engine operator that debuted on the Nasdaq in 2005."
China’s Baidu picks clsa, goldman for Hong Kong listing. According to Bloomberg Quint on Thursday, 7 January, "Nasdaq-listed Baidu plans to sell shares in the Asian financial hub as soon as the first half of this year, the people said, asking not to be identified as the information isn't public. ", "Representatives for CLSA and Goldman Sachs declined to comment, while a representative for Baidu had no immediate comment."
EV dreams power Baidu but May not last. According to The Wall Street Journal on Thursday, 7 January, "It makes sense for Baidu to consider making its own cars, especially when investors are paying attention to anything and everything EV-related. "
According to CNBC on Thursday, 7 January, "Baidu (BIDU) - Baidu has chosen Goldman Sachs (GS) and CLSA for its planned Hong Kong listing, according to a Bloomberg report. "
Chinese tech giant Baidu is seeking to raise $3.5 billion in a Hong Kong stock listing, report says. According to Business Insider on Thursday, 7 January, "However, Baidu will face stiff competition in an already stacked Chinese EV market. ", "In 2017, Baidu established an autonomous driving unit called Apollo that has worked with established carmakers like Ford. "
China’s Baidu teams with geely on electric cars. According to Bloomberg Quint on Friday, 8 January, "Geely's shares soared as much as 10% in Hong Kong, while Baidu gained 2% in New York. "
According to Bloomberg Quint on Friday, 8 January, "jumped as much as 22% to the highest since 1993 after reports it is teaming with Baidu Inc. to make EVs for the Chinese market."
5. UGI Corporation
10.8% sales growth and 13.36% return on equity
UGI Corporation distributes, stores, transports, and markets energy products and related services in the United States and internationally.
UGI Corporation's sales growth this year is anticipated to be 8.6% and 2.4% for next year.
Year-on-year quarterly revenue growth declined by 2.2%, now sitting on 6.56B for the twelve trailing months.
UGI Corporation's sales growth for the next quarter is 10.8%. The company's growth estimates for the ongoing quarter and the next is 1.7% and 12.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.36%.
Volatility
UGI Corporation's last day, last week, and last month's average volatility was a positive 0.03%, a negative 0.04%, and a negative 0.14%, respectively.
UGI Corporation's last day, last week, and last month's high and low average amplitude percentage was 2.34%, 2.14%, and 2.31%, respectively.
UGI Corporation's Stock Yearly Top and Bottom Value
UGI Corporation's stock is valued at $34.56 at 07:22 EST, way below its 52-week high of $45.26 and way above its 52-week low of $21.75.
UGI Corporation's Moving Average
UGI Corporation's worth is under its 50-day moving average of $35.76 and higher than its 200-day moving average of $33.87.6. Bridge Bancorp, Inc.
18.6% sales growth and 9.47% return on equity
Bridge Bancorp, Inc. operates as the bank holding company for the BNB Bank that provide commercial and consumer banking products and services to small businesses, and municipal and consumer relationships.
Bridge Bancorp, Inc.'s sales growth this year is expected to be 12.3% and a negative 0.2% for next year.
Year-on-year quarterly revenue growth grew by 9.6%, now sitting on 164.52M for the twelve trailing months.
Bridge Bancorp, Inc.'s sales growth for the next quarter is 18.6%. The company's growth estimates for the present quarter and the next is 1.4% and 80.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.47%.
Volatility
Bridge Bancorp, Inc.'s last day, last week, and last month's average volatility was a positive 0.04%, a negative 0.24%, and a positive 0.23%, respectively.
Bridge Bancorp, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 2.61%, 2.33%, and 3.71%, respectively.
Bridge Bancorp, Inc.'s Stock Yearly Top and Bottom Value
Bridge Bancorp, Inc.'s stock is valued at $24.18 at 07:22 EST, way below its 52-week high of $33.67 and way higher than its 52-week low of $16.51.
Bridge Bancorp, Inc.'s Moving Average
Bridge Bancorp, Inc.'s value is above its 50-day moving average of $23.42 and way above its 200-day moving average of $20.54.7. Civista Bancshares, Inc.
11.4% sales growth and 8.9% return on equity
Civista Bancshares, Inc. operates as the financial holding company for Civista Bank that provides community banking services.
Civista Bancshares, Inc. 's sales growth this year is anticipated to be 9.6% and 0.8% for next year.
Year-on-year quarterly revenue growth grew by 3.3%, now sitting on 104.81M for the twelve trailing months.
Civista Bancshares, Inc. 's sales growth for the next quarter is 11.4%. The company's growth estimates for the current quarter and the next is a negative 8.5% and 10.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.9%.
Volatility
Civista Bancshares, Inc. 's last day, last week, and last month's average volatility was a negative 1.77%, a positive 0.35%, and a positive 0.15%, respectively.
Civista Bancshares, Inc. 's last day, last week, and last month's high and low average amplitude percentage was 2.12%, 2.72%, and 2.74%, respectively.
Civista Bancshares, Inc. 's Stock Yearly Top and Bottom Value
Civista Bancshares, Inc. 's stock is valued at $17.53 at 07:22 EST, way under its 52-week high of $23.88 and way higher than its 52-week low of $11.25.
Civista Bancshares, Inc. 's Moving Average
Civista Bancshares, Inc. 's value is above its 50-day moving average of $17.01 and way higher than its 200-day moving average of $14.73.8. Amedisys Inc
14% sales growth and 24.62% return on equity
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States.
Amedisys Inc's sales growth this year is anticipated to be 5.8% and 11.1% for next year.
Year-on-year quarterly revenue growth grew by 10%, now sitting on 2.02B for the twelve trailing months.
Amedisys Inc's sales growth for the next quarter is 14%. The company's growth estimates for the current quarter and the next is 55.3% and 40%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.62%.
Volatility
Amedisys Inc's last day, last week, and last month's average volatility was 1.47%, 0.24%, and 0.81%, respectively.
Amedisys Inc's last day, last week, and last month's high and low average amplitude percentage was 3.40%, 3.04%, and 2.87%, respectively.
Amedisys Inc's Stock Yearly Top and Bottom Value
Amedisys Inc's stock is valued at $293.33 at 07:22 EST, under its 52-week high of $298.54 and way higher than its 52-week low of $132.95.